Archive

Category: Uncategorized

The Concomitant Use of Calcium and Diltiazem for Rapid Atrial Fibrillation

Background: Atrial fibrillation and atrial flutter with rapid ventricular rate (AF/AFL with RVR) are the most common subtypes of SVT, comprising a large number of ED visits in aging populations. Currently, rhythm and rate control are the mainstays of therapy ...

Read More
Cardiovascular

REBEL Cast Ep119: A Discussion with Scott Weingart on the CT FIRST Trial

Back on June 1st, 2023, Swami wrote a blog post on REBEL EM titled, The CT FIRST Trial, Should We Pan-CT After ROSC?.  This stemmed a lot of discussion in the background between Swami, myself, and Scott.  We felt it ...

Read More
Resuscitation

REBEL Cast Ep 118: The PROCOAG Trial – 4F-PCC for Trauma Patients?

Background: Hemorrhage is the leading cause of mortality in trauma patients.  Interventions such as early application of hemorrhage control, tranexamic acid, reduction of crystalloid  fluid administration and balanced ratio blood product transfusion have improved many patients’ outcomes. However, mortality still ...

Read More
Trauma

The COVID-OUT Trial: Does Metformin Reduce the Risk of Long COVID?

Background: The COVID-19 pandemic has been the focus of massive research efforts over the last three years. Our understanding of the disease and effective treatments to reduce mortality have progressed rapidly during this time. However, the medical community is only ...

Read More
Infectious Disease

Rethinking the Role of TXA: Are We Asking Too Much?

Background: Injuries are a major cause of death worldwide. Hemorrhage accounts for about 1/3 of all trauma deaths and as such, it should be our goal to find treatments to decrease death from hemorrhage. Our bodies have a finely tuned ...

Read More
Trauma
Showing Slide 1 of 6

Sponsored